Reboxetine may be helpful in the treatment of amphetamine withdrawal.

@article{Cox2004ReboxetineMB,
  title={Reboxetine may be helpful in the treatment of amphetamine withdrawal.},
  author={D. Cox and R. Bowers and A. Mcbride},
  journal={British journal of clinical pharmacology},
  year={2004},
  volume={58 1},
  pages={
          100-1
        }
}
Illicit amphetamine use is widespread internationally [1], amphetamine and MDMA are the second most commonly used drugs in the European Union after cannabis [2]. There have been alarming epidemics of amphetamine use, particularly metamphetamines, in South-east Asian countries in the last few years. Clients undergoing withdrawal from amphetamines can pose a range of challenges to services traditionally orientated towards managing opiate or alcohol withdrawal. Not least of these challenges is the… Expand
Treatment for amphetamine withdrawal.
TLDR
Amineptine showed reduction in discontinuation rates and improvement in clinical presentation compared to placebo, but had no effect on reducing withdrawal symptoms or craving, and is not available for use due to concerns over abuse liability when using the drug. Expand
Monotherapy with reboxetine in amphetamine withdrawal syndrome
TLDR
The findings in this case suggest that reboxetine may constitute an interesting alternative for the treatment of amphetamine withdrawal syndrome (AWS), and shows that noradrenaline plays an important role in the modulation of the response to amphetamines. Expand
Neurochemical Consequences of Dysphoric State During Amphetamine Withdrawal in Animal Models: A Review
TLDR
This review focuses on the molecular aspects of AM PH withdrawal as indexed by neurochemical parameters under a variety of injection regimens in rodent models which exhibit significant phenotypic features relevant to the syndromes of AMPH withdrawal in humans. Expand
Reboxetine in clinical practice: a review.
TLDR
The aim of the present review is to summarize and discuss the last literature findings, comparing risks and benefits of reboxetine usage in everyday clinical practice. Expand
Neural substrates of psychostimulant withdrawal-induced anhedonia.
TLDR
Great progress has been made in understanding the neural substrates of anhedonia associated with psychostimulant withdrawal, which may also shed light on the neurobiology of nondrug-inducedAnhedonia, such as that seen as a core symptom of depression and a negative symptom of schizophrenia. Expand
Involvement of NO/NMDA-R pathway in the behavioral despair induced by amphetamine withdrawal
TLDR
Both NO and NMDA-R pathways are involved and related to each other in depression induced following AW, and the antidepressant-like effect of co-injection of sub-effective doses of MK-801 with AG suggested that inducible nitric oxide synthase (iNOS) is associated with NMda-R in AW induced depression. Expand
Agmatine: Identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians
TLDR
The results indicate that a change in agmatine signaling is a common mechanism in the withdrawal caused by these drugs, at least in planarians, and demonstrate that ag matine exposure blocks withdrawal to three different drugs in planaria. Expand
Putting the call out for more research: the poor evidence base for treating methamphetamine withdrawal.
TLDR
A systematic review exposed a lack of well-conducted research targeted towards the management of methamphetamine withdrawal and further research is essential to ensure the development of more targeted, timely and effective withdrawal treatment interventions. Expand
Dexamphetamine substitute‐prescribing in pregnancy: a 10‐year retrospective audit
Background: In the UK dexamphetamine has been used widely as a treatment for amphetamine users. We sought to study the effects of illicit amphetamine use on pregnancy, and to evaluate the safety andExpand
Psychostimulant withdrawal as an inducing condition in animal models of depression
TLDR
It is propound that the psychostimulant withdrawal model displays high levels of predictive and construct validity, and recent progress and limitations in the development of this model, as well as future directions for research, are evaluated and discussed. Expand
...
1
2
...